Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2025 Jun 18;21(6):e1012839. doi: 10.1371/journal.ppat.1012839

Experimental evolution of a pathogen confronted with innate immune memory increases variation in virulence

Ana Korša 1,*,#, Moritz Baur 1,#, Nora K E Schulz 1, Jaime M Anaya-Rojas 1, Alexander Mellmann 2, Joachim Kurtz 1,*
Editor: Robert L Unckless3
PMCID: PMC12176410  PMID: 40532126

Abstract

Understanding the drivers and mechanisms of virulence evolution is still a major goal of evolutionary biologists and epidemiologists. Theory predicts that the way virulence evolves depends on the balance between the benefits and costs it provides to pathogen fitness. Additionally, host responses to infections, such as resistance or tolerance, play a critical role in shaping virulence evolution. But, while the evolution of pathogens has been traditionally studied under the selection pressure of host adaptive immunity, less is known about their evolution when confronted to simpler and less effective forms of immunity such as immune priming. In this study, we used a well-established insect model for immune priming – red flour beetles and their bacterial pathogen Bacillus thuringiensis tenebrionis – to test how this form of innate immune memory drives the pathogen evolution. Through controlled experimental evolution of the pathogen in primed versus non-primed hosts, we found no change in average virulence after eight selection cycles in primed host. Nonetheless, we observed a notable rise in the variability of virulence, defined as the ability to kill hosts, among independent pathogen lines that evolved in primed hosts, and the bacteria were unable to develop resistance to host priming. Whole genome sequencing revealed increased activity in the bacterial mobilome (prophages and plasmids). Expression of the Cry toxin – a well-known virulence factor – was linked to evolved differences in copy number variation of the cry-carrying plasmid, though this did not correlate directly with virulence. These findings highlight that innate immune memory can drive variability in pathogen traits, which may favor adaptation to variable environments. This underscores the need to consider pathogen evolution in response to innate immune memory when applying these mechanisms in medicine, aquaculture, pest control, and insect mass production.

Author summary

Understanding pathogen evolution is crucial for science and public health. A key question is whether pathogens evolve variations in virulence, which quantifies the harm inflicted on the host. While research often focuses on pathogens confronted with their hosts’ adaptive immune system, less is known about pathogen evolution in response to simpler kinds of immunity. Immune priming is a form of memory in the innate immune system of invertebrates. In this study we used red flour beetles and their bacterial pathogen Bacillus thuringiensis tenebrionis as a model to explore immune priming’s influence on pathogen evolution. After eight infection cycles in primed or control hosts, pathogens in primed hosts showed higher virulence variability compared to controls. Bacteria did not develop resistance to immune priming, indicating response robustness. Genetic analysis revealed increased activity in mobile genetic elements, including prophages and plasmids, with variations in a virulence-related plasmid encoding the Cry toxin. These findings suggest innate immune memory can promote diversity in pathogen traits, influencing adaptation in unpredictable environments. Our results highlight the importance of considering pathogen evolution in response to innate immune memory, especially when applying immune priming strategies in medicine, agriculture, and pest control.

Introduction

Virulence is usually defined as the ability of a pathogen to reduce host fitness (or its components, e.g., survival during the infection process [1,2]. The direction in which virulence evolves in an evolutionary arms race often depends on the balance between the benefits and costs it provides to the pathogen. For instance, when the highly virulent Myxoma virus was introduced into Australian rabbit populations in the 1950s, it evolved to intermediate levels of virulence while maximizing its fitness [35]. In contrast to highly virulent strains that rapidly kill hosts—potentially reducing transmission opportunities—intermediate virulence allows for sustained infection and transmission while still overcoming host defences. In this example, the cost associated with high virulence was host death, which limited pathogen transmission. Although transmission of pathogens varies and some pathogens can only be transmitted after host death, several studies have shown that optimal transmission rates happen at intermediate levels of virulence [68]. Additionally, several experimental evolution studies have revealed the complexity of selection processes acting on both hosts and pathogens during their rapid coadaptation [9,10] in which the coevolution between the host and pathogen favours and maintains intermediate levels of pathogen virulence [10].

Host responses and defence mechanisms against pathogens also play a crucial role in the evolution of virulence. Depending on the ability of organisms to resist or tolerate infections, pathogen virulence evolution can take different trajectories [11]. The evolution of tolerance, for instance, can strongly influence the evolution of virulence by allowing pathogens to evolve higher transmission rates without increasing the actual level of virulence in tolerant hosts. Consequently, pathogens can develop extreme virulence in hosts lacking tolerance, potentially leading to devastating epidemics. This occurs because non-tolerant hosts are incapable of reducing the damage caused by high pathogen burdens, which results in elevated mortality rates [11]. Likewise, epidemiological and mathematical studies propose that “leaky” vaccines that do not offer complete immunity might allow pathogens to continue spreading and developing greater virulence, thus making them more dangerous to unvaccinated individuals [3,1214]. On the other hand, leaky vaccines can also lead to reduced pathogen virulence through the reduction of pathogen load [15].

Virulence evolution is a complex trait that may also be influenced by interactions with the hosts’ microbiome [16]. A recent experimental evolution study in nematodes and the pathogen Pseudomonas aeruginosa revealed that incomplete host immunity that allows infection with reduced disease severity, caused by host microbiota, favours the evolution of higher pathogen virulence [17]. Moreover, it has been demonstrated that the external immune defences of red flour beetles, specifically their antimicrobial quinone-rich secretions, can influence the evolution of pathogens, leading to increased virulence in pathogens like Metarhizium brunneum [18]. On the other hand, the presence of defensive microbes within the host, as demonstrated in Caenorhabditis elegans infected with Serratia marcescens, can lead to the evolution of reduced pathogen virulence by limiting pathogen success and transmission [19]. The above examples illustrate how host immunity can influence the evolutionary trajectories of pathogen virulence in different ways. More empirical data from experimental evolution studies across diverse host-pathogen systems are necessary to gain a broader understanding of the conditions under which host immunity promotes higher or lower pathogen virulence.

Invertebrate innate immune priming has been suggested to be analogous to leaky vaccination, as primed individuals can still become infected but also can tolerate elevated pathogen loads, providing an experimental system to assess the effect of innate immune memory on pathogen evolution [20]. Immune priming is a form of immune memory provided by the innate immune system, where initial non–lethal pathogen exposure can lead to enhanced protection upon secondary exposure [2123]. Over the last couple of decades, the body of evidence for immune priming in invertebrates has been constantly growing [2426] and experimental evolution studies revealed the rapid evolution of immune priming [27,28]. Innate immune systems of vertebrates show similar phenomena, in the form of trained immunity [29,30]. The relevance and potential applications of these forms of innate immune memory are currently intensively discussed [3133]. While it has been observed that priming reduces pathogen transmission [34], we still, however, lack empirical data regarding the effects of these innate forms of immune memory on pathogen evolution and virulence.

In this study, we used the red flour beetle Tribolium castaneum and its natural pathogen Bacillus thuringiensis tenebrionis (Btt), to investigate how host priming influences the evolutionary trajectories of pathogen virulence. T. castaneum is a well-established model for host-pathogen coevolution and immune priming [3537] and shows a specific priming response towards the spore-forming pathogen Btt after both septic and oral exposure [3840]. Bacillus thuringiensis (Bt), widespread and commonly present in diverse environments, produces insecticidal crystal proteins known as Cry toxins, specifically toxic to different insect orders [41]. Insects usually ingest Bt spores while feeding on contaminated food sources. After the spores are ingested orally, Bt can infect and reproduce within beetle larvae, ultimately leading to host death [42,43]. Upon host death, Bt undergoes sporulation inside the cadaver, producing new spores that are subsequently released into the environment. In nature, other hosts can encounter these spores either by scavenging infected cadavers or through environmental contamination. The repeated exposure of T. castaneum larvae to Btt spores in nature suggests that immune priming may be ecologically relevant, potentially influencing both host resistance and pathogen evolution over time. The oral priming response in our lab is triggered by the ingestion of the sterile filtered supernatant of the spore culture [39], which induces the upregulation of immune genes [44]. For example, previous research has shown that recognition genes and reactive oxygen species (ROS)-related genes are upregulated following oral priming with Btt suggesting heightened state of immune “alertness” characterized by increased expression of recognition genes and elevated ROS-based defences. In contrast, antimicrobial peptide genes (AMP) genes and genes involved in cellular responses were shown to be only up-regulated upon Btt infection and not priming [44].

To investigate how host immune priming influences the evolution of pathogen virulence, we experimentally evolved Btt in primed and non-primed beetle larvae for eight evolution cycles (Fig 1). During the experiment, beetles were not allowed to evolve by taking them from a stock population (i.e., one-sided evolution of the pathogen). After the eight cycles of experimental evolution, we compared the levels of virulence (proportion of mortality) and transmission (number of spores produced in cadavers of evolved Btt lines in primed and control host environment). We also sequenced the genomes of evolved Btt to identify whether genetic changes contributed to evolved differences in virulence. To our knowledge, our study is the first to show the influence of insect specific immune priming on pathogen evolution, thus broadening our understanding of how host innate immune memory might influence the trajectories of virulence evolution.

Fig 1. Experimental design.

Fig 1

We inoculated one colony of the pathogen Bacillus thuringiensis tenebrionis (Btt) into 100 mL of Btt medium. After 7 days of sporulation, we harvested the spores, adjusted the concentration to 5x10^9, and produced an infection diet that was offered to individual primed and control 15 days old beetle larvae (n = 192 per replicate line and cycle). For each selection cycle, we used Btt spores from cadavers of T. castaneum larvae killed by the infection in the previous cycle and produced eight bacterial lines per selection treatment. For each bacterial line, we isolated spores from five cadavers, which were subsequently grown independently in a sporulation medium to achieve high spore numbers for the infection of a sufficient number of beetle larvae for the next infection cycle. In each selection cycle, bacteria reproduced and sporulated within their host followed by amplification in culture medium. We had eight independently evolving pathogen replicate lines each for evolution in control and primed hosts. After eight selection cycles, we phenotyped and genotyped all evolved pathogen lines (P1-8, C1-8) and the ancestral pathogen. For the ancestral pathogen, we produced pseudo-replicates (A1-8), i.e., lines that had not undergone any selection process, but had grown in separate flasks to control for possible variations from growth in the medium. For phenotyping, we quantified virulence (proportion of host mortality) and transmission (spore growth in cadavers) in two different host environments (primed and control). We also measured spore growth in a liquid medium. For genotyping, we sequenced the whole genomes of the 24 lines and quantified phage and plasmid coverage. We also measured the expression of a key virulence factor, the Cry-encoding gene, with RT-qPCR. Insect drawings by Helle Jensen.

Results

Does host immune priming affect pathogen virulence evolution?

B. thuringiensis tenebrionis (Btt) bacteria evolved experimentally in either immune primed or control (i.e., non-primed) T. castaneum hosts (Fig 1, left side). After this selection treatment for eight cycles, we analysed the response of Btt to the selection pressure encountered in primed vs. control hosts. Previous research has indicated that Btt completes roughly 9.5 generations within the host [43], leading us to estimate that our experiment involved approximately 76 generations in the host. We then compared the virulence (measured as host mortality) of eight primed-evolved Btt lines (P1-8) and eight control-evolved Btt lines (C1-8) as well as ancestral Btt (eight replicates directly taken from stock Btt, A1-8). These phenotypic readouts (Fig 1, right side) were taken from two environments, primed and control host, thereby establishing a ‘common-garden’ experiment.

We found that both, the selection treatment (Fig 1, left side) and the host environment (Fig 1, right side) significantly affected pathogen virulence (Fig 2A; glmer (mortality~ selection_treatment*host environment) +(1|Replicate_line)+ (1|Block)+(1|Plate): X2 = 74.25, Df = 5, p < 0.001). Selection in primed and control hosts significantly reduced the virulence, compared to the ancestral pathogen (control: p = 0.001; primed: p = 0.006). Furthermore, virulence of evolved lines was lower in the primed compared to control host environment (p < 0.001). This shows that priming was still efficient, also against the lines that had evolved in the primed hosts (Fig 2A).

Fig 2. Virulence (proportion of host mortality) of pathogen lines.

Fig 2

A. Correlation between the virulence in primed and control hosts, showing raw data of each independent replicate in primed and control host environment larvae. The dotted line shows where the mortality rates of control and primed hosts would be equal. All pathogen lines are below this line, indicating lower pathogen virulence in primed compared to control hosts (i.e., a ‘priming effect’). In panels B to E, large solid circles represent the posterior mean of the Bayesian model, and the smaller circles the raw data corresponding to the independent pathogen replicate line. Additionally, the thick and thin bars represent the 68% and 95% HDI, equivalent to a normal distribution’s 1 and 2 standard deviations. Panels B and C show the virulence in control and primed host environments. Panels D and E show posterior estimates of k-CV, which is a measure of dispersion, calculated from the coefficient of variation. Points show the median estimates, and error bars represent the credible intervals (HDCI), indicating uncertainty.

We then performed separate analyses for primed and control host environments to see how individual bacterial lines vary in virulence in different host environments. To do that we modelled the effects of the selection treatments using a Beta distribution in a Bayesian framework and allowed the selection treatments to influence the precision parameter (ϕ). The mortality of control hosts infected with primed-evolved bacteria had an 85.15% probability of being higher than when infected with bacteria from the control pathogen lines, though the estimated difference remained small (6.6%, 95% CI: [-5.5, 18.7], see Fig 2B). In the primed host environment (Fig 2C), we found a similar pattern, with a 59.87% probability of higher mortality when primed hosts were infected with bacteria from the primed lines compared to when they were infected with bacteria from the control lines. However, the estimated difference was minimal (1.4%, 95% HDI: [-8.1, 12.3%]).

In terms of relative variability (i.e., coefficient of variation, k-CV), primed-evolved bacteria had a 96.6% probability of higher variability in virulence than control-evolved bacteria when infecting the control host (Fig 2D) and there was a 12.2% average increase in variability in virulence in primed-evolved bacteria (95% HDI: [-1.5, 27.6]). The relative variability in virulence in primed-evolved pathogens was not different from the variability of control-evolved bacteria when in primed host environment (1.8%, 95% HDI: [-15.3, 10.4], Fig 2E). However, the magnitude of variation in virulence was much higher in primed hosts than in control hosts.

Do the evolved pathogens differ in spore production, sensitivity to priming and fitness?

To evaluate the spore production of the evolved bacteria, we measured the pathogen spore load in cadavers and the spore production in liquid medium. As Btt likely transmits through spores produced in cadavers [45], we considered the spore load a good proxy of the transmission rate. There was no difference in spore production between selection treatments in the control host (Fig 3A; lmer: X2 = 0.859, Df = 2, p = 0.650), but in primed hosts, pathogens that had evolved in primed and control hosts produced fewer spores than the ancestral Btt (Fig 3B; lmer: X2 = 8.807, Df = 2, p = 0.0122; primed-evolved: p = 0.014, control-evolved: p = 0.020). We also examined the correlation between spore load and virulence for all bacteria lines and selection treatments in the primed and control host environments but found no correlation (Figs 3C, S1 and S2). Finally, selection treatment had a significant effect on spore production in a liquid medium (F = 40.087, Df = 2, p < 0.001), where both primed-evolved and control-evolved pathogens exhibited lower spore production than the ancestral Btt (Fig 3D).

Fig 3. Spore growth in A) primed and B) control hosts. The dots correspond to the mean of ten measurements for each independent pathogen line.

Fig 3

The plot shows the mean and the confidence intervals. Ancestral Btt produced more spores than both evolved lines, but only in the primed host environment (lmer: X 2 = 8.808, Df = 2, p = 0.012, and there seemed to be a weak difference in pathogen load between the evolved lines (p = 0.973). Letters denote significant differences between the selection treatments. C. Correlation between the spore load in primed and control hosts, showing the number of spores each independent replicate produces in primed and control beetle cadaver. The dotted line shows where the spore load in control hosts and primed hosts would be equal. D Spore growth in the medium. Each dot represents the mean of three independent measures of one pathogen line. The graph shows the mean and confidence intervals. Primed- and control-evolved lines produced fewer spores than the ancestral strain (p < 0.001).

Additionally, we calculated the priming sensitivity of bacterial replicates by dividing virulence in control hosts by virulence in primed hosts. This gave us a value indicating how sensitive the pathogen is to the priming response of the host (Fig 4A). The more sensitive to priming the pathogen is, the lower the virulence in the primed hosts would be. Selection treatment showed a trend in affecting the priming sensitivity (X2 = 5.985, Df = 2, p = 0.050), with the primed-evolved pathogen exhibiting a trend (p = 0.058) toward higher priming sensitivity compared to the ancestral pathogen (Fig 4A).

Fig 4. Priming sensitivity and fitness in the host.

Fig 4

Each dot corresponds to bacterial replicate line and the box shows mean and confidence intervals. A Priming sensitivity of bacterial replicates was calculated by dividing the proportion of mortality in control/the proportion of mortality in primed hosts. The higher the value, the more sensitive the pathogen is towards host priming. Selection treatment affected the priming sensitivity (X2 = 5.985, Df = 2, p = 0.050), with the primed-evolved pathogen exhibiting the highest priming sensitivity compared to the ancestral pathogen (p = 0.058). B Fitness in the host of each bacterial line was calculated as mortality proportion X spore load. Selection treatment and host environment significantly influenced host fitness (X 2 = 40.385, df = 5, p < 0.001). Pairwise comparisons confirmed that all the selection treatment levels have lower fitness in the priming host environment. C Pearson’s correlation between priming sensitivity and average fitness in the host (mean of fitness in primed and control host environment). A, C, and P stand for evolution treatment levels: Ancestral, Control, and Primed evolved pathogen, respectively.

We also assessed the fitness of each bacterial line within the host by combining mortality rates and spore load data (Fig 4B). Our analysis revealed that both selection treatments and host environment significantly influenced pathogen fitness (X2 = 40.385, df = 5, p < 0.001). The primed host environment showed a significant negative effect on pathogen fitness (Estimate = -1.03, p = 0.0012), indicating that the within-host fitness in the priming environment is lower than in the control environment. We finally tested whether priming sensitivity was correlated with pathogen fitness, and found a negative trend for the primed-evolved pathogens (Fig 4C). Pathogens with higher fitness seem to be less impacted by the host’s primed immune response. This suggests that these fitter strains may have evolved strategies to evade or resist the immunological effects associated with priming.

Do the evolved pathogens differ in Cry gene expression?

Cry is an important virulence factor of Bt, but it can be costly, leading some bacteria to potentially lose it [10,41,46,47]. We tested for potential differences in cry3a gene expression, as evolved differences in virulence might be related to this important virulence factor. For this, we performed qPCR on RNA extracted from overnight cultures. In contrast to the negative control (Btt without Cry3a), all tested lines expressed Cry3a (S2 Table). To comprehensively assess these differences, we first analyzed the data by pooling all evolved lines together. Building on this, we then performed statistical comparisons for each experimental line relative to the ancestral strain, allowing us to pinpoint specific evolutionary changes.

Overall, the expression in the evolved lines did not differ significantly from that in the ancestral strain (C: estimate = -0.7565, Df = 14, t = -0.597, p = 0.560; P: estimate = -1.1444, Df = 14, t = -0.903, p = 0.382). Four of the control- and three of the primed-evolved lines showed significantly reduced cry3a gene expression compared to the ancestral strain (S3 Table and S3 Fig). However, we found no association between cry3Aa expression and virulence of the lines, neither in primed (t = 0.279, Df = 15, p = 0.783) nor in control host environment (t = 0.131, Df = 15, p = 0.897)

Do the evolved pathogens differ in their genomes and mobilome?

To investigate whether the observed phenotypes of the evolved Btt lines are based on genetic changes, we performed whole genome sequencing of all evolved lines and three replicates of the ancestral pathogen. Compared to the ancestral pathogen, the evolved lines showed a low number of single nucleotide variants (SNVs) and structural variants (SV). Overall, 32 unique variants were identified. The primed-evolved lines contained 30 variants and the control-evolved lines contained 28 variants. Only a few of those variants were shared across different replicates and no distinctive pattern could be observed between the primed and control evolution regime (Fig 5). Common variants in at least 50% of lines included a G to T substitution in an intergenic region between a hypothetical protein and a putative NTP pyrophosphohydrolase (g.2017894G > T), and a small insertion within a hypothetical protein coding sequence (g.2776026insA), causing a frameshift (Fig 5). Lines C1 and P8 both had unique variants in the same hypothetical protein DUF4430 at different positions: while C1 had a small deletion (g.3358458delC), P8 had an insertion (g.3357970insCAGCTGTTCGTTATATAAATACGCAA). Both variants caused frameshifts, with the P8 insertion also introducing a premature stop codon.

Fig 5. Heatmap displaying the identified single nucleotide variants (SNVs) and structural variants (SVs) at the respective genomic positions.

Fig 5

Variants in any line with an alternative allele fraction of >=10% of total read coverage are displayed. Alternative allele fraction of each variant for all remaining lines was calculated by dividing alternative allele coverage by total read coverage at that position (red = 100% alternative allele or fraction 1, yellow = 0% alternative allele or fraction 0). Individual lines are ordered within the respective evolution treatment by virulence (cf. Fig 2), from low to high (arrows).

As most bacteria are host to a multitude of mobile genetic elements that can influence the performance in changing environments, we aimed at identifying differences in such elements between the evolution regimes. The NCBI reference sequence [48] contains six plasmid contigs where the two biggest plasmids are 250kb and 188kb, followed by two plasmids of 77kb, 68kb and the smallest 15kb plasmids. The 44kb plasmid is a phagemid, a circularized phage, which additionally is located on the chromosome of the reference sequence and thus was not included in the plasmid coverage analysis. The analysis for plasmid coverage in comparison to chromosome coverage indicated a decrease in the abundance of the 188kb plasmid in the evolved lines compared to the ancestral lines (Fig 6A). However, only line P8 retained a plasmid-to-host ratio similar to the ancestral for this plasmid (S3 Fig). This particular plasmid encodes for the important crystal toxin Cry3Aa and other virulence factors (Cry15Aa, Sphingomyelinase C). Additionally, we observed correlation of the log2 transformed Cry3Aa gene-to-chromosome ratio and the relative expression of the cry3Aa gene measured via qPCR expression previously described (Figs 6B and S3). However, correlation of other phenotypic traits with active mobile elements showed no statistical significance (S7 Fig). The coverage plots across the genome contained peaks in distinct areas of the chromosome (S4 Fig) that partially overlapped with annotated prophage areas known as Bacillus phages [49]. We found that the phages phBC6A52, phi4J1 and phiCM3 had the greatest differences in phage-to-host ratio (Fig 7). We performed double-layer agar assays (DLAs) for two out of 8 lines of each evolution environment and the ancestral strain to verify that phages were active in the evolved lines, but not in the ancestral strain. As expected, we observed visible round plaques in the bacterial lawns of the evolved lines, but not the ancestral lines (S6 Fig).

Fig 6. A Log2 transformed plasmid coverage divided by chromosome coverage (relative plasmid coverage).

Fig 6

Shown are the respective mean values and their standard error. * adjusted p < 0.05 B Correlation of the Log2 transformed cry3Aa gene coverage divided by chromosome coverage (relative cry3Aa gene coverage) and delta CT of housekeeping gene expression subtracted by cry3Aa gene expression (relative cry3Aa gene expression). The p-value from the linear regression analysis (lm(Cry_expr ~ Cry_cov)) indicates a significant effect of cry3Aa gene coverage on cry3Aa gene expression.

Fig 7. Analysis of log2 transformed values of phage coverage divided by chromosome coverage (relative phage coverage).

Fig 7

A = Heatmap for each replicate line. A = ancestral, C = control evolved, P = primed evolved. The lines are ordered by evolution treatment and by virulence where the arrow indicates the increase of virulence. Colour gradient indicates high to middle to low relative phage coverage (red to yellow to blue). B Mean values of relative phage coverage for selection treatment and their standard error. * adjusted p < 0.05.

Discussion

To investigate the potential effects of immune priming on virulence evolution, we conducted one-sided experimental evolution with Btt, using either primed or non-primed control T. castaneum beetle hosts, and evaluated the phenotype and genotype of the evolved pathogen lines. While average virulence (measured as the proportion of dead hosts), did not differ strongly between these selection environments, we identified priming as a selective pressure leading to increased variation in virulence when tested in the control host environment (Fig 2D). Some primed-evolved lines showed higher virulence than any of the control-evolved lines and similar to the ancestral Btt, whereas other primed-evolved lines caused the lowest host mortality rates (Fig 2A). Another important observation is that the primed-evolved pathogens did not adapt better to the primed host environment. Host priming remained effective and reduced mortality also against the primed-evolved pathogens (Fig 2A), which were moreover not able to increase spore production in primed hosts (Fig 3B). This implies that the primed-evolved pathogens failed to develop mechanisms to evade the host’s priming immune response. Even the most virulent lines did not overcome the primed immune response, indicating that priming serves as a robust protective measure for the host.

Although in both our experimental evolution regimes we extracted bacteria from larvae that died by infection – selecting for high virulence, we observed lower virulence in the evolved lines than in the ancestral Btt. This can probably be attributed to one-sided adaptation in Btt, as the host lacks the opportunity to evolve. Previous studies have shown that high virulence may not be favoured due to its associated costs when host co-adaptation is restricted [10,50]. Additionally, because certain virulence factors are costly and encoded on mobile elements, bacteria may lose them, particularly when propagated in a medium, as demonstrated in previous research [10,47]. Indeed, we found a reduction in the overall coverage of the 188kb plasmid encoding for several virulence factors, as well as differences in the expression of the cry3Aa gene that correlated with its genomic coverage (Fig 7). A reduction in Cry toxin production and plasmid carriage during passaging experiments has been shown in other studies using B. thuringiensis [51]. Such losses can be explained by the advantage of “cheating” cells within a population of Bt that do not express cry3Aa anymore and thereby gain a growth advantage [51]. However, in our experiment, cry3Aa expression alone did not explain variation in virulence, and the replicate with the low virulence (P2) did not change in cry3Aa expression compared to the ancestral strain, whereas the replicate with the high virulence (P7) showed significantly lower cry3Aa expression (S2 Fig). Although surprising, this result might be related to the less straightforward role of the Cry3Aa toxin for Btt virulence in T. castaneum [51,52], compared to other insects. For example, in contrast to other systems, purified Cry toxin alone does not induce beetle mortality, but rather a combination of spores and toxins is required for lethal effects [46,52]. Moreover, a recent study indicates that Cry toxins are involved in the induction of the priming response [53]. Thus, evolution in primed hosts might select against high Cry expression, which in turn could make other virulence factors such as chitinases, metalloproteases or vegetative insecticidal proteins more relevant in these evolved lines [41,54]. Finally, previous studies have shown that evolution can result in reduced virulence due to the interaction with defensive microbes of the host [19] or due to antagonistic interactions among different pathogen strains [55]. A previous study has shown that immune priming leads to changes in the microbiome, specifically by increasing the abundance of pre-existing Bacillus taxa [56]. This shift in microbiome composition could create a competitive environment in the beetle gut, where the infecting Btt pathogen experiences antagonistic interactions with resident Bacillus species.

Compared to ancestral Btt, evolved Btt showed reduced sporulation in liquid medium as well as in primed hosts (Fig 3). This decline in sporulation may be attributed to the presence of active prophages that we identified in the genomes of the evolved lines (Fig 7). The activation of prophages and the transition from lysogeny (dormant state) to the lytic cycle (active viral replication and bacterial cell lysis) are often triggered by environmental factors [57]. Such stress can occur under constant sporulation conditions and is known to cause losses in other Bacillus fermentation and to interfere with the evolution of virulence of phages towards their bacterial host [58,59]. Interestingly, that a reduction of spore production of evolved lines occurred only in primed but not control hosts (Fig 4A and 4B) could suggest that phage induction is primarily promoted in primed hosts. This environment represents a more stressful niche for the pathogen, as priming leads to the damage in the gut of T. castaneum larvae, triggering an early physiological stress response along with the upregulation of immune related genes [60]. Additionally, antagonistic competition may maintain these phages [61]. Bacillus is a member of the microbiome of T. castaneum and immune priming can cause a shift towards higher abundance of Bacillus species [56]. Releasing lytic phages could provide a competitive advantage by targeting members of the same genus or species.

While observing changes in phages and plasmids, we could not pinpoint any common chromosomal mutations that are specific to the selection treatments (Fig 6). This does not exclude that there might be more subtle genetic changes that went undetected because they might be specific to certain replicates. Indeed, the observed increase in variation in virulence indicates that replicates may take different evolutionary routes [62] making it difficult to find common genetic changes.

Moreover, the lack of a link between spore load and virulence might suggest that Btt virulence and transmission evolve independently. A comparable result was noted in the pathogen Pseudomonas aeruginosa following evolution in hosts with partial immunity [17]. Unlike our findings, the incomplete immunity in that study resulted in increased pathogen virulence. Nevertheless, our results are in line with the mentioned study that revealed that the most virulent pathogens did not develop mechanisms to counteract the protective benefits of priming exposure. It is worth noting, however, that in this case, the priming or partial host immunity was non-specific and triggered by the host’s microbiota, while in our study priming is specific for the bacterial strain and triggered by pathogen-derived cues present in the supernatants used for priming [39,40,53,60]. Finally, different host-pathogen systems may show divergent evolutionary trajectories.

The increased variance in virulence in primed-evolved hosts might be explained by the more variable niche that a primed host represents for the pathogen [63]. Btt in primed T. castaneum hosts are confronted with an increased intensity and diversity of immune defences [44], which are characterised by dynamic changes over time, as well as variability among host individuals and lines [28]. Therefore, the hostile host environment of an immune primed host likely represents a more stressful environment for the pathogen. Moreover, pathogens in primed hosts are exposed to a changed microbiome composition [56]. Immune-primed hosts could thus represent a fluctuating environment, which is known to increase phenotypic and genetic diversity [6466], allowing pathogens to retain the flexibility to adapt to diverse host conditions over time. We indeed found the magnitude of variation in virulence to be much higher in primed hosts than in control hosts (Fig 2E). Moreover, variance in the pathogen population could also result from antagonistic pleiotropy involving active phages that could be beneficial in one, but detrimental in another environment [66]. Lytic phages are well known to be activated in stressful environments and could thereby contribute to variation among pathogens [67].

Interestingly, despite the increased variance, pathogen lines evolved in primed hosts exhibited greater priming sensitivity, showing lower virulence (Fig 4A) in primed hosts compared to ancestral and control-evolved Btt lines. This could suggest that the primed environment does not necessarily select for higher virulence in the short term but instead leads to divergent evolutionary trajectories. It is possible that given more generations, clearer patterns of adaptation— increases in virulence—might emerge as our results indicate that the primed-evolved pathogen is 85.15% more likely to have higher virulence than the control The observed trend of a negative association between the fitness of the primed-evolved pathogen and its priming sensitivity suggests that pathogen strains with higher fitness are less affected by the host’s primed immune response (Fig 4). This indicates that fitter pathogens may have developed strategies to more effectively resist or evade the immunological effects of host priming. Previous research has demonstrated that B. thuringiensis can suppress the humoral immune system of the diamondback moth [68]. Additionally, it has been found that T. castaneum shows a unique immune response when orally infected with B. thuringiensis. In particular, genes linked to the Toll and Imd pathways were found to be downregulated after oral infection [69]. Future studies could focus on relevant immune markers in the host, to determine whether evolved pathogens actively suppress immune responses. This would help clarify whether the observed fitness differences among strains result from enhanced immune evasion mechanisms.

Our observation of increased virulence variation may also result from differences in our system compared to models of leaky vaccines, where the pathogen is directly transmitted between vaccinated hosts [12,14,70]. In contrast, B. thuringiensis, both in our experiment as well as in nature, experiences two distinct environments, as it can thrive outside of its insect hosts [71]. In addition to host factors, the longevity of spores and their ability to persist in the environment may also play a role in determining virulence [72].

In conclusion, our results provide, to our knowledge. the first evidence of how bacterial pathogens evolve in response to specific immune priming of their hosts. The observed increase in virulence is evolutionarily significant, as variation is essential for selection to act upon. Increased variance in a subpopulation evolving with primed hosts may fuel the evolutionary flexibility of the entire pathogen population, as diversity within bacterial communities significantly influences their survival within hosts [73] enhancing the overall resilience of the population [74,75]. Therefore, host immune priming and other forms of incomplete, innate immune memory, may boost the evolutionary potential of pathogens and even lead to multiple evolutionary stable states [11]. This is important because innate immune memory bears a large potential for applications. The growing importance of trained immunity in medicine is being paralleled by the increasing applications of immune priming in invertebrates, particularly in sectors such as aquaculture and large-scale insect production. Both areas are experiencing significant advancements and garnering increased attention [76,77]. Studies in further systems with immune priming and trained immunity are needed to better understand and potentially manage the evolution of pathogens when confronted with innate immune memory.

Materials and methods

Model organisms

We utilized Bacillus thuringiensis subspecies morrisoni biovar tenebrionis (Btt) as the pathogen, sourced from the Bacillus Genetic Stock Centre (BGSCID) at Ohio State University, USA, identified by the code 4AA1. The strain was preserved in 500 µL microtubes with 25% glycerol at a temperature of -80°C. This strain has been shown to cause mortality in T. castaneum larvae upon the oral ingestion of spores and their toxins [42,43].

As the host, we used a wild-type T. castaneum (Cro1) population collected from Croatia in 2010 [42] and adapted to laboratory conditions for eight years in numerous non-overlapping generations until the start of the experiment in 2018. Beetles were reared on organic wheat flour (Bio Weizenmehl Type 550, DM-drogerie Markt GmbH + Co. KG) supplemented with 5% brewer’s yeast (the flour mixture was heat-sterilised at 75°C for 24 h). For rearing and infection experiments, beetles were kept at 30°C, 70% relative humidity, and a 12-h/12-h-light–dark cycle.

Experimental evolution

Preparation of bacteria for selection treatment and infections.

We prepared spore cultures and supernatants as previously [39,40], with minor modifications. To begin the selection experiment, we plated Btt vegetative cells from the -80°C glycerol stock on an LB agar plate and incubated it overnight at 30°C. The following day, we inoculated 5 ml of Bt medium (w/V–0.75% Bacto Peptone (Sigma), 0.1% glucose, 0.34% KH2PO4, 0.435% K2HPO4) that was supplemented with 25 μl of a sterile salt solution (0.2 M MgSO4, two mM MnSO4, 17 mM ZnSO4, and 26 mM FeSO4) and 6.25 μl of sterile 1 M CaCl2 × 2H2O with a single colony, and incubated it at 30°C and 200 rpm overnight. Overnight cultures were moved to 1-L Erlenmeyer flasks containing 300ml of Bt medium supplemented with 1.5 mL of salt solution and 375 μL 1 M CaCl2 × 2H2O. Since Btt is naturally neomycin-resistant, 15µg/µL of neomycin were added to the sporulation media. This step was taken to guarantee that other spore-forming bacteria that could come from cadavers did not proliferate in the medium. The cultures were kept at 30°C and rotated at 180 rpm for seven days in the dark. On the third day of incubation, 1.5 mL of salt solution and 375 μL of 1 M CaCl2 × 2H2O were added to the cultures. Following seven days of sporulation, the culture was spun for 20 minutes at 4500 rpm. The pellet was washed and redispersed in PBS (Calbiochem). Using means of flow cytometry (FACSCanto II; Becton Dickinson, USA) as previously described [43] spore concentration was adjusted to 5 x 10^9/mL, and the diet was prepared by adding heat-sterilized flour with yeast (0.15 g/mL of spore suspension; [42,43]. We then pipetted the liquid spore-containing diet (10 µL per well) into the 96 flat bottom microtiter plates (Sarstedt, Germany) under sterile conditions, covered them with a breathable sealing foil for culture plates (Kisker Biotech), and dried them overnight (~17 hours) at 30°C. For all remaining selection cycle experiments, where spores were taken from cadavers, we slightly adjusted the protocol; after processing spores, we inoculated 50 mL of Bt medium supplemented with salts and neomycin in a 100 ml Erlenmeyer flask, followed by seven days incubation at 180 rpm and 30°C.

Preparation of primed and control host for the selection treatment.

The primed host environments were performed as previously described [39,40]. Btt vegetative cells were plated from a -80°C glycerol stock on LB agar plates and incubated overnight at 30°C. Five single colonies were incubated overnight, and sporulation cultures were produced as described above but without adding neomycin. After seven days of sporulation and centrifugation, the collected supernatants were centrifuged twice at 4,500 rpm for 15 min and then filter-sterilized with a 0.45-μm pore-size, followed by a 0.2-μm pore-size cellulose acetate filter (Whatman GmbH). We mixed every millilitre of spore-free supernatant with 0.15 g heat-treated flour (supplemented with 5% yeast). Next, ten microliter of the priming diet mixture was pipetted into each well of a 96-well plate (Sarstedt, Germany), sealed with a breathable foil (Kisker Biotech), and dried overnight at 30°C. For the control treatment, the diet was prepared by mixing 0.15 g heat-treated, yeast-supplemented flour with each millilitre of sterile non-conditioned growth medium.

For every selection treatment cycle, we took approximately 2,000 1-month-old adults and left them to lay eggs for 24 hours on the flour. The priming protocol was as follows: 15 days after oviposition, 192 larvae per replicate line were individually placed on a previously prepared priming diet in two 96-well flat-bottom plates. The plates were sealed with clear tape and punctured with needles to allow air circulation and were stored under standard rearing conditions. After 24h on a priming diet, we transferred larvae to flour discs consisting of phosphate-buffered saline (PBS) mixed with 0.15 g/mL flour, in which they stayed for four days until we transferred them again to pathogen spore-containing discs.

Re-infection for another selection treatment cycle.

We measured mortality for seven days and then collected larvae that died during the first two days, placed them in the dark, and waited for another seven days to ensure that all Btt cells in the cadaver had sporulated. For reinfection, we isolated spores from insect cadavers and propagated them once in liquid sporulation media to obtain a sufficient number of spores for infection. For each bacterial line, we isolated spores from five cadavers, which were subsequently grown independently in a growth medium to achieve high spore numbers for the infection of a sufficient number of beetle larvae for the next infection cycle. Spores from the five cultures derived from the cadavers were combined for infection to reduce the effect of potential clonal interference among rapidly growing clones in culture. We randomly selected five cadavers per individual line and individually homogenized them as described before [43]. We then counted spore concentrations using flow cytometry and pasteurized the suspensions at 80°C for 10 minutes (i.e., any possible vegetative cells are killed). Liquid medium was inoculated with 1mL of 1x10^6 spores derived from cadavers for germination, followed by spore production. After seven days of incubation, we pooled all five individually raised spore cultures and prepared the spore-flour diet. Primed and control host larvae were then placed on spore flour discs, and their survival was tracked.

Phenotypic readouts

Virulence and spore production of evolved bacterial lines.

All the selection treatment lines were introduced to a primed and control host environment. Host mortality was screened for six days. We performed this experiment in three experimental blocks, with 48 larvae per treatment/block, resulting in 144 larvae per treatment combination. For every block, we took approximately 2,000 1-month-old adults and left them to lay eggs on the flour (implemented with 5% yeast) for 24 hours, following the priming protocol described above. For each block, we prepared 12 96-well plates with a priming diet and 12 96-well plates with control diet. We placed 15-day-old larvae on the plates and, after 24 hours, transferred them to PBS flour discs. After four days, we transferred them to 96-well plates containing spores from 24 bacterial lines (eight Primed evolved, Control evolved and Ancestral). Each 96-well plate contained spores from all 24 bacterial lines to control for the possible plate effect. This resulted in 24 96-well plates for each experimental block.

Spores from the bacterial lines were prepared as described above. Frozen spores from the 8th passage and ancestral Btt were first plated on an agar plate and after 14 hours 10 colonies were inoculated in 50 mL growth medium supplemented with salts. After seven days of bacterial growth and sporulation, spores were washed, and measured via flow cytometry, and the concentration was adjusted to 5x109cells/mL. We used measures of the numbers of spores in a liquid medium from three experimental blocks to test for the differences in spore production between the lines.

We quantified the pathogen load of infected larvae that died from the infection. For this, we took ten cadavers per bacterial line, which resulted in a total of 240 cadaver samples. The samples were processed as described before [43]. Seven days after their death, each cadaver was placed in a 100 µl Eppendorf tube with 50 µL PBS and a sterile metal bead. The cadavers were homogenized using a Mixer Mill MM301 (Retsch) to release spores into the solution. The solution was then washed using a cell strainer to remove larger particles. The solution was diluted 1:1000 and measured via flow cytometry.

We quantified Btt fitness by calculating the product of spore load and host mortality rate. As an obligate killer, Btt’s reproductive success relies on both its capacity to infect and kill hosts and the number of spores produced per infected host.

Cry gene expression in Btt cultures.

Before RNA extraction, we inoculated two cultures of ancestral and evolved lines in 6 mL LB medium at 30°C, 180 rpm. Following 12 h of incubation, the cultures were centrifuged at 4500 rpm for 10 min and resuspended in 100 µL of PBS. We added 2.2 µl of lysozyme (100 mg/mL) to 100 µL of the bacterial suspension and incubated for 30 min at 37°C with shaking. Subsequently, we implemented an RNA extraction protocol with a combination of TRIzol reagent (Ambion, USA) lysis and extraction with the purification via spin columns from the SV Total RNA Isolation System (Promega) as described before [78]. To analyze cry3a expression, cDNA synthesis, and qPCR were performed in two identically designed blocks. We conducted reverse transcription of cDNA using the RevertAid First Strand cDNA Synthesis Kit (ThermoScientific) following the manufacturer’s instructions. For the reaction, we used 2µL of extracted RNA, irrespective of its concentration, along with a random hexamer primer. The resulting cDNA product was then diluted 1:5 with nuclease-free water.

Following cDNA synthesis, we performed qPCR. This analysis involved measuring the expression of cry3a relative to two housekeeping genes (yqey and rps21) (S1 Table). Prior to the main experiment, we determined the amplification efficiency of the primers by qPCR using a serial 10-fold dilution of the initial cDNA input (S1 Table).

Genome analysis

Sequencing.

After culturing samples from all evolved and three ancestral replicate lines on LB agar plates, we extracted DNA using the Monarch Genomic DNA Purification Kit (New England Biolabs GmbH, Frankfurt am Main, Germany). For each evolutionary line, we inoculated 10 independent overnight cultures from single colonies, extracted DNA from these cultures, and pooled the samples before sequencing. This approach allowed us to capture the genetic diversity within each evolved population rather than focusing on individual clones. For sequencing on the PacBio Sequel Ile platform (Pacific Biosciences Inc., Menlo Park, CA, USA), we created a library with the SMRTbell Express Template Prep Kit 2.0 (Pacific Biosciences Inc.) according to the manufacturer’s recommendations, aiming for at least 20x coverage on the HiFi read level. We then mapped the resulting HiFi reads against the sequence of a Btt reference strain (NCBI accession no.: GCF_022810725.1) using the SMRT Link software version 11.

Variant detection.

To call single nucleotide variants (SNVs) we used GATK Haplotypecaller (v4.3.0.0) [79] and Google’s DeepVariant [80] on the Galaxy Server (Galaxy Version 1.5.0 + galaxy1). We then intersected the resulting vcf files of the evolved lines with those derived from the ancestral lines using the bcftools isec function (version 1.16) [81] to filter out variants that were based on differences between our ancestral lines and the used reference sequence. Of the remaining SNVs we kept those with an alternative allele fraction of>= 10% of the total read coverage at the respective position. To call structural variants (SVs) we used Sniffles2 (Version 2.2) [82], The resulting vcf files were intersected in the same way as the SNV vcf files. Next, we verified all final variants by manually inspecting them in the Integrative Genomics Viewer (IGV) [83]. To annotate the SNVs we used SnpEff (version 5.2c (build 2024-04-09 12:24)) [84] using the prokaryotic codon table and the reference genbank- and nucleotide fasta files.

Plasmid coverage.

We calculated the coverage across the chromosome and the different reference plasmids respectively using samtools depth (version 1.16.1) [81] and estimated the abundance of plasmids by dividing each plasmids mean coverage by the chromosomes mean coverage and taking the log2 of those values. We termed the resulting values “Log2(Plasmid-to-Host ratio)”.

Phage analysis.

To detect potentially complete prophage genomes within our reference genome we used PHASTER [85]. Next, we calculated the coverage across the genome using samtools depth and divided the genome into sections of a) outside of prophage regions and b) within prophage regions. We considered b) to be true if the region contained all essential phage genes necessary for its reproduction (from small terminase to lysis cassette). Finally, we divided the means of b) by the means of a) and took the log2 of those ratios. We termed the resulting values “Log2(Phage-to-Host ratio)”. The log2 transformed Phage-to-Host ratios were then plotted using ggplot2 in Rstudio. To confirm the presence of active phages in the evolved lines, we performed double-layer agar assays (DLA). In short, we grew bacteria in 20 ml Luria broth (LB) medium overnight. The next morning, we adjusted the overnight culture to an optical density of 1 at 600 nm wavelength (OD600 of 1) and inoculated 500 µL into 50 ml fresh LB medium. After four hours, 8 hours, and 12 hours, we took 1 ml of the culture and adjusted it to an OD600 of 1.5. We then mixed 400 µl of the culture with 4 ml lukewarm 0.7% LB agar and poured the mix onto a solid 1.5% LB agar plate. After 24 h, we checked the plates for plaques in the bacterial lawn.

Statistics

All data were analysed using R [86] and R Studio [87]. To test whether the pathogen selection treatment and host environment have an effect on the virulence, we tested the effect of selection treatment (primed-evolved, control-evolved and ancestral) on the host survival by fitting a generalized linear mixed effect model with interaction (GLMM) and binomial error distribution using the glmer function in the package lme4 [88] (mortality~ selection_treatment*host environment) +(1|Replicate_line)+ (1|Block)+(1|Plate). The selection treatment level and host environment were defined as fixed factors, whereas a bacterial line, plate and block were defined as random factor. As interaction was not significant, we then fitted a model with selection treatment as a fixed factor in primed and control host environments separately. To further test the selection influence of mortality variation, we ran a Bayesian Beta regression model in rstan [89], allowing the precision parameter (ϕ) to be influenced by the Selection treatment. Traditional models often assume constant variance in survival models, which may not hold when survival rates vary across groups. The Beta distribution allows flexible modeling of survival probabilities, capturing different survival patterns while accounting for heteroscedasticity. Its variance depends on both the mean survival proportion (μ) and the precision parameter (ϕ), ensuring a more accurate representation of uncertainty in survival outcomes. We used the model’s posterior samples to estimate the probability that mortality variation arising from primed, control, and ancestral populations are different. The variance of the response variable in a beta regression depends on both μ and ϕ, calculated as Var(Y)=μ(1 − μ)/ 1 + ϕ. We used this estimated variance to estimate the K-CV, a more robust measurement of covariation [90]. We used the posterior estimates of K-CV and Var(Y) to calculate the fold change (log2) of virulence variation for the control and prime pathogen lines and report the mean and 95% Highest Density Interval.

For spore load (transmission) analysis, the lmer function in the lme4 package was used with the bacterial line as a random factor (spore_load~ selection_treatment +(1|replicate_line) in primed and control host environment separately. For spore growth analysis we performed linear regression analysis with lm function. After fitting the models, the variance between the selection treatment (primed-evolved, control-evolved, ancestral) was assessed using one-way analysis of variance. The means were compared using Tukey’s post-hoc analysis with Benjamini-Hochberg correction.

Priming sensitivity of each bacterial replicate was determined by dividing proportion of mortality in control host with proportion of mortality in primed host. Kruskal-Wallis test was used to assess differences in priming sensitivity between the selection treatment levels. The means were compared using post-hoc pairwise comparisons using Dunn’s test with a Benjamini-Hochberg correction.

We determined fitness in the host by combining spore load and proportion of mortality per individual bacterial line. Then we compared it between selection treatment levels using lmer function (Fitness_in_host ~ Line * Environment + (1 | Replicate_line). The means were compared using Tukey’s post-hoc analysis with Benjamini-Hochberg correction.

To analyze gene expression data from qPCRs, we first compared the relative expression of cry3a of the primed and control-evolved Btt to the expression in the ancestral Btt cultures in a linear mixed model with experimental block and evolved replicates as random factors (relative expression ~ selection_treatment + (1|block) + (1|replicate)) using the packages lme4 and lmerTests [91]. We also fitted a second linear mixed effects model using the same packages to compare the evolved lines to the ancestral cultures (relative expression ~ selection_treatment + (1|block)).

We used various statistical techniques to evaluate the relationships among different variables. The connections between spore load and mortality, mortality and cry expression, and average host fitness with priming sensitivity were analyzed using Pearson’s correlation method. We conducted Mann-Whitney tests using the wilcox.test() function to evaluate the significance of differences between log2 transformed Plasmid-to-Host and Phage-to-Host ratios. The p.adjust() function with the “holm” adjustment method was applied to address multiple testing concerns. A linear model was constructed to investigate significant interactions between the read coverage for the cry3Aa gene and its expression. The cor() function from the R Stats package (version 4.3.1) was used to determine the correlation strength between different phenotypic readouts and active mobile elements for both primed evolved lines and control evolved lines. To statistically compare the correlation strengths of various readouts between primed and control evolved lines, we utilized the cocor() package (version 1.1-4) [92].

Supporting information

S1 Table. qPCR primers and their amplification efficiencies.

(DOCX)

ppat.1012839.s001.docx (12.7KB, docx)
S2 Table. Relative expression of Cry3a gene in cultures from different Btt strains.

Btt- and Bt407- do not carry the Cry3a gene. Priming and control lines were evolved from ancestral strain. Mean ΔCt values by subtracting the target gene Ct value from the geometric mean of the Ct values of the housekeeping genes.

(DOCX)

ppat.1012839.s002.docx (12.8KB, docx)
S3 Table. Differences of Cry3a gene expression of individual evolved lines compared to the ancestral strain.

Shown are the results of linear mixed effects model with block as experimental factor. Significant differences are shown in bold type face.

(DOCX)

ppat.1012839.s003.docx (14.2KB, docx)
S1 Fig. Correlation between spore load and virulence in ancestral line (A), control line(C) and primed line (P) in primed hosts.

(DOCX)

ppat.1012839.s004.docx (19.7KB, docx)
S2 Fig. Correlation between spore load and virulence in ancestral line (A), control line(C) and primed line (P) in primed beetle larvae in control host.

(DOCX)

ppat.1012839.s005.docx (19.3KB, docx)
S3 Fig. Relative expression of Cry3a gene for evolved lines.

ΔCt values were calculated by subtracting the Ct value of the target gene, Cry3A from the geometric mean of the Ct values of two housekeeping genes (Yqey and rps21).

(DOCX)

ppat.1012839.s006.docx (91.5KB, docx)
S4 Fig. Heatmap for the Log2 transformed values of plasmid coverage divided by chromosome coverage for each replicate line.

A = ancestral, C = control evolved, P = primed evolved.

(DOCX)

ppat.1012839.s007.docx (59.2KB, docx)
S5 Fig. Exemplary log2 transformed mean-normalized coverage plots of reads across the chromosome for control (C1 – 4) and priming (P1 – 4) evolved lines.

(DOCX)

ppat.1012839.s008.docx (161.5KB, docx)
S6 Fig. Double layer agar assays of an ancestral line A and evolved lines C1 (control evolved) and P7 (priming evolved).

(DOCX)

ppat.1012839.s009.docx (724.1KB, docx)
S7 Fig. Pearson correlation matrix for the primed evolved pathogen (A, C) and the control evolved pathogen (B, D).

Correlated traits include all phenotypic traits with active mobile elements (A, B) or Fitness and Priming sensitivity values with active mobile elements (C, D).

(DOCX)

ppat.1012839.s010.docx (77KB, docx)

Acknowledgments

We thank Nicholas Carl Heinrich Schröder, Katharina Natascha Meyer zu Riemsloh and Kathrin Brüggemann for assisting in the lab during experimental evolution, Stefan Bletz for supporting whole genome sequencing procedures, Barbara Milutinović for valuable comments and suggestions, and Helle Jensen for the drawings of larvae.

Data Availability

The genomic sequences can be found on NCBI under Bioproject number: PRJNA1174726. All the data sets, code, and RMarkdown file with figures and analysis results can be found in Zenodo depository: https://doi.org/10.5281/zenodo.15050213

Funding Statement

This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the Research Training Group GRK 2220 “Evolutionary Processes in Adaptation and Disease,” project number 281125614 to JK and partial funding within SFB TRR 212 (NC³) – Project numbers 316099922 and 396780003 (to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Casadevall A, Pirofski LA. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun. 1999;67(8):3703–13. doi: 10.1128/IAI.67.8.3703-3713.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Read AF. The evolution of virulence. Trends Microbiol. 1994;2(3):73–6. doi: 10.1016/0966-842x(94)90537-1 [DOI] [PubMed] [Google Scholar]
  • 3.Mackinnon MJ, Gandon S, Read AF. Virulence evolution in response to vaccination: The case of malaria. Vaccine. 2008;26(Suppl 3(48-5)): C42–C52. doi: . doi:10.1016/j.vaccine.2008.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schmid-Hempel P. Evolutionary Parasitology: The Integrated Study of Infections, Immunology, Ecology, and Genetics [Internet]. Oxford University Press; 2013. [cited 2023 Jul 18]. Available from: doi: 10.1093/acprof:oso/9780199229482.001.0001 [DOI] [Google Scholar]
  • 5.Fenner F, Marshall ID. A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America. J Hyg (Lond). 1957;55(2):149–91. doi: 10.1017/s0022172400037098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bérénos C, Schmid-Hempel P, Wegner KM. Evolution of host resistance and trade-offs between virulence and transmission potential in an obligately killing parasite. J Evol Biol. 2009;22(10):2049–56. doi: 10.1111/j.1420-9101.2009.01821.x [DOI] [PubMed] [Google Scholar]
  • 7.Jensen KH, Little TJ, Skorping A, Ebert D. Empirical support for optimal virulence in a castrating parasite. PLoS Biol. 2006;4(7):e197. doi: 10.1371/journal.pbio.0040197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Day T, Kennedy DA, Read AF, Gandon S. Pathogen evolution during vaccination campaigns. PLoS Biol. 2022;20(9):e3001804. doi: 10.1371/journal.pbio.3001804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Papkou A, Guzella T, Yang W, Koepper S, Pees B, Schalkowski R, et al. The genomic basis of Red Queen dynamics during rapid reciprocal host–pathogen coevolution. Proc Natl Acad Sci. 2019;116(3):923–8. 10.1073/pnas.1810402116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Masri L, Branca A, Sheppard AE, Papkou A, Laehnemann D, Guenther PS, et al. ; Host–pathogen coevolution: The selective advantage of Bacillus thuringiensis virulence and its cry toxin genes. PLoS Biol. 2015;13(6): e1002169. doi: 10.1371/journal.pbio.1002169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Best A, White A, Boots M. The coevolutionary implications of host tolerance. Evolution. 2014;68(5):1426–35. doi.org/10.1111/evo.12368 [DOI] [PubMed] [Google Scholar]
  • 12.Gandon S, Mackinnon MJ, Nee S, Read AF. Imperfect vaccines and the evolution of pathogen virulence. Nature. 2001;414(6865):751–6. doi: 10.1038/414751a [DOI] [PubMed] [Google Scholar]
  • 13.Boots M. The Need for Evolutionarily Rational Disease Interventions: Vaccination Can Select for Higher Virulence. PLoS Biol. 2015;13(8):e1002236. doi: 10.1371/journal.pbio.1002236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Read AF, Baigent SJ, Powers C, Kgosana LB, Blackwell L, Smith LP, et al. Imperfect vaccination can enhance the transmission of highly virulent pathogens. PLoS Biol. 2015;13(7): e1002198. doi:10.1371/journal.pbio.1002198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bailey RI, Cheng HH, Chase-Topping M, Mays JK, Anacleto O, Dunn JR, et al. Pathogen transmission from vaccinated hosts can cause dose-dependent reduction in virulence. PLoS Biol. 2020;18(3):e3000619. doi: 10.1371/journal.pbio.3000619 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Armitage SA, Genersch E, McMahon DP, Rafaluk-Mohr C, Rolff J. Tripartite interactions: how immunity, microbiota and pathogens interact and affect pathogen virulence evolution. Curr Opin Insect Sci. 2022;50: 100871. doi: 10.1016/j.cois.2021.12.011. [DOI] [PubMed] [Google Scholar]
  • 17.Hoang KL, Read TD, King KC. Incomplete immunity in a natural animal-microbiota interaction selects for higher pathogen virulence. Curr Biol. 2024;34(6):1357–63.e3. doi:10.1016/j.cub.2024.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rafaluk C, Yang W, Mitschke A, Rosenstiel P, Schulenburg H, Joop G. Highly potent host external immunity acts as a strong selective force enhancing rapid parasite virulence evolution. Environ Microbiol. 2017;19(5): 2090–2100. doi: https://doi.org/10.1111/1462-2920.13736. [DOI] [PubMed] [Google Scholar]
  • 19.Ford SA, Kao D, Williams D, King KC. Microbe-mediated host defence drives the evolution of reduced pathogen virulence. Nat Commun. 2016;7:13430. doi: 10.1038/ncomms13430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Tate AT. A general model for the influence of immune priming on disease prevalence. Oikos. 2017;126(3):350–60. doi: https://doi.org/10.1111/oik.03274. [Google Scholar]
  • 21.Kurtz J, Franz K. Innate defence: evidence for memory in invertebrate immunity. Nature. 2003;425(6953):37–8. doi: 10.1038/425037a [DOI] [PubMed] [Google Scholar]
  • 22.Little TJ, Kraaijeveld AR. Ecological and evolutionary implications of immunological priming in invertebrates. Trends Ecol Evol. 2004;19(2):58–60. doi: 10.1016/j.tree.2003.11.011 [DOI] [PubMed] [Google Scholar]
  • 23.Schmid-Hempel P. Evolutionary ecology of insect immune defenses. Annu Rev Entomol. 2005;50(0): :529-51. doi: 10.1146/annurev.ento.50.071803.130420. [DOI] [PubMed] [Google Scholar]
  • 24.Milutinović B, Kurtz J. Immune memory in invertebrates. Semin Immunol. 2016;28(4):328–42. doi: 10.1016/j.smim.2016.05.004 [DOI] [PubMed] [Google Scholar]
  • 25.Contreras-Garduno J, Lanz-Medoza H, Franco B, Nava A, Pedraza-Reyes M, Canales-Lazcano J. Insect immune priming: ecology and experimental evidences. Ecol Entomol. 2016;41(4):351–66. doi: 10.1111/een.12300. [DOI] [Google Scholar]
  • 26.Subhagan SR, Pathrose B, Chellappan M. Harnessing immune priming: A double‐edged defence mechanism in insects. Physiol Entomol. 2024;50(1):10–27. doi: 10.1111/phen.12465 [DOI] [Google Scholar]
  • 27.Khan I, Prakash A, Agashe D. Experimental evolution of insect immune memory versus pathogen resistance. Proc R Soc B Biol Sci. 2017;284(1869):20171583. doi: 10.1098/rspb.2017.1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ferro K, Peuß R, Yang W, Rosenstiel P, Schulenburg H, Kurtz J. Experimental evolution of immunological specificity. Proc Natl Acad Sci U S A. 2019;116(41):20598–604. doi: 10.1073/pnas.1904828116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Netea MG, Quintin J, van der Meer JWM. Trained immunity: a memory for innate host defense. Cell Host Microbe. 2011;9(5):355–61. doi: 10.1016/j.chom.2011.04.006 [DOI] [PubMed] [Google Scholar]
  • 30.Gourbal B, Pinaud S, Beckers GJM, Van Der Meer JWM, Conrath U, Netea MG. Innate immune memory: An evolutionary perspective. Immunol Rev. 2018;281(1): 21–40.; doi: 10.1111/imr.12647. [DOI] [PubMed] [Google Scholar]
  • 31.Ziogas A, Bruno M, van der Meel R, Mulder WJM, Netea MG. Trained immunity: target for prophylaxis and therapy. Cell Host Microbe. 2023;31(11):1776–91. doi: 10.1016/j.chom.2023.10.015. [DOI] [PubMed] [Google Scholar]
  • 32.Ali Mohammadie Kojour M, Baliarsingh S, Jang HA, Yun K, Park KB, Lee JE. Current knowledge of immune priming in invertebrates, emphasizing studies on Tenebrio molitor. Dev Comp Immunol. 2022;127: 104284. doi: 10.1016/j.dci.2021.104284. [DOI] [PubMed] [Google Scholar]
  • 33.Yang W, Tran NT, Zhu CH, Yao DF, Aweya JJ, Gong Y, et al. Immune priming in shellfish: A review and an updating mechanistic insight focused on cellular and humoral responses. Aquaculture. 2021;530: 735831. doi: 10.1016/j.aquaculture.2020.735831. [DOI] [Google Scholar]
  • 34.Prakash A, Fenner F, Shit B, Salminen TS, Monteith KM, Khan I, et al. IMD-mediated innate immune priming increases Drosophila survival and reduces pathogen transmission. PLoS Pathog. 2024;20(6):e1012308. doi: 10.1371/journal.ppat.1012308 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Tate AT, Andolfatto P, Demuth JP, Graham AL. The within-host dynamics of infection in trans-generationally primed flour beetles. Mol Ecol. 2017;26(14):3794–807. doi: https://doi.org/10.1111/mec.14088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Khan I, Prakash A, Agashe D. Divergent immune priming responses across flour beetle life stages and populations. Ecol Evol. 2016;6(21):7847–55. doi: 10.1002/ece3.2532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Pointer MD, Gage MJG, Spurgin LG. Tribolium beetles as a model system in evolution and ecology. Heredity (Edinb). 2021;126(6):869–83. doi: 10.1038/s41437-021-00420-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Roth O, Sadd BM, Schmid-Hempel P, Kurtz J. Strain-specific priming of resistance in the red flour beetle, Tribolium castaneum. Proc R Soc B Biol Sci. 2009;276(1654): 145–151. doi: 10.1098/rspb.2008.1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Milutinović B, Fritzlar S, Kurtz J. Increased survival in the red flour beetle after oral priming with bacteria-conditioned media. J Innate Immun. 2014;6(3): 306–314. doi: 10.1159/000355211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Futo M, Sell MP, Kutzer MAM, Kurtz J. Specificity of oral immune priming in the red flour beetle Tribolium castaneum. Biol Lett. 2017;13(12):20170632. doi: 10.1098/rsbl.2017.0632 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Palma L, Muñoz D, Berry C, Murillo J, Caballero P. Bacillus thuringiensis toxins: an overview of their biocidal activity. Toxins (Basel). 2014;6(12):3296–325. doi: 10.3390/toxins6123296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Milutinović B, Stolpe C, Peuß R, Armitage SAO, Kurtz J. The red flour beetle as a model for bacterial oral infections. PLoS ONE. 2013;8(5): e64638. doi: 10.1371/journal.pone.0064638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Milutinović B, Höfling C, Futo M, Scharsack JP, Kurtz J. Infection of Tribolium castaneum with Bacillus thuringiensis: quantification of bacterial replication within cadavers, transmission via cannibalism, and inhibition of spore germination. Appl Environ Microbiol. 2015;81(23):8135–44. doi: 10.1128/AEM.02051-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Greenwood JM, Milutinović B, Peuß R, Behrens S, Esser D, Rosenstiel P, et al. Oral immune priming with Bacillus thuringiensis induces a shift in the gene expression of Tribolium castaneum larvae. BMC Genomics. 2017. ;18(1)): 329–326. doi: 10.1186/s12864-017-3705-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Raymond B, Johnston PR, Nielsen-LeRoux C, Lereclus D, Crickmore N. Bacillus thuringiensis: an impotent pathogen? Trends Microbiol. 2010;18(5):189–94. doi: 10.1016/j.tim.2010.02.006 [DOI] [PubMed] [Google Scholar]
  • 46.Li RS, Jarrett P, Burges HD. Importance of spores, crystals, and δ-endotoxins in the pathogenicity of different varieties of Bacillus thuringiensis in Galleria mellonella and Pieris brassicae. J Invertebr Pathol. 1987;50(3):277–84. doi: https://doi.org/10.1016/0022-2011(87)90093-0. [Google Scholar]
  • 47.Sheppard AE, Nakad R, Saebelfeld M, Masche AC, Dierking K, Schulenburg H. High instability of a nematicidal Cry toxin plasmid in Bacillus thuringiensis. J Invertebr Pathol. 2016;133:34–40. doi: 10.1016/j.jip.2015.11.009 [DOI] [PubMed] [Google Scholar]
  • 48.NCBI [Internet]. [cited 2024 Nov 26]. Bacillus thuringiensis serovar morrisoni str. 4AA1 genome assembly ASM2281072v1. Available from: https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_022810725.1/ [Google Scholar]
  • 49.Gillis A, Mahillon J. An improved method for rapid generation and screening of Bacillus thuringiensis phage-resistant mutants. J Microbiol Methods. 2014;106:101–3. doi: 10.1016/j.mimet.2014.08.012 [DOI] [PubMed] [Google Scholar]
  • 50.Mikonranta L, Mappes J, Laakso J, Ketola T. Within-host evolution decreases virulence in an opportunistic bacterial pathogen. BMC Evol Biol. 2015;15:165. doi: 10.1186/s12862-015-0447-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Dimitriu T, Souissi W, Morwool P, Darby A, Crickmore N, Raymond B. Selecting for infectivity across metapopulations can increase virulence in the social microbe Bacillus thuringiensis. Evol Appl. 2023;16(3):705–20. doi: 10.1111/eva.13529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Oppert B, Morgan TD, Kramer KJ. Efficacy of Bacillus thuringiensis Cry3Aa protoxin and protease inhibitors against coleopteran storage pests. Pest Manag Sci. 2011;67(5):568–73. doi: 10.1002/ps.2099 [DOI] [PubMed] [Google Scholar]
  • 53.Länger ZM, Baur M, Korša A, Eirich J, Lindeza AS, Zanchi C, et al. Differential proteome profiling of bacterial culture supernatants reveals candidates for the induction of oral immune priming in the red flour beetle. Biol Lett. 2023;19(11):20230322. doi: 10.1098/rsbl.2023.0322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Malovichko YV, Nizhnikov AA, Antonets KS. Repertoire of the bacillus thuringiensis virulence factors unrelated to major classes of protein toxins and its role in specificity of host-pathogen interactions. Toxins. 2019;11(6)): 347. doi: 10.3390/toxins11060347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Garbutt J, Bonsall MB, Wright DJ, Raymond B. Antagonistic competition moderates virulence in Bacillus thuringiensis. Ecol Lett. 2011;14(8):765–72. doi: 10.1111/j.1461-0248.2011.01638.x [DOI] [PubMed] [Google Scholar]
  • 56.Korša A, Lo LK, Gandhi S, Bang C, Kurtz J. Oral Immune Priming Treatment Alters Microbiome Composition in the Red Flour Beetle Tribolium castaneum. Front Microbiol. 2022;13:793143. doi: 10.3389/fmicb.2022.793143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Wendling CC, Refardt D, Hall AR. Fitness benefits to bacteria of carrying prophages and prophage-encoded antibiotic-resistance genes peak in different environments. Evolution. 2021;75(2):515–28. doi: 10.1111/evo.14153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Liao Z, Liu Y, Wei H, He X, Wang Z, Zhuang Z, et al. Effects of dietary supplementation of Bacillus subtilis DSM 32315 on growth, immune response and acute ammonia stress tolerance of Nile tilapia (Oreochromis niloticus) fed with high or low protein diets. Anim Nutr. 2023;15:375–85. doi: 10.1016/j.aninu.2023.05.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Dragoš A, Priyadarshini B, Hasan Z, Strube ML, Kempen PJ, Maróti G, et al. Pervasive prophage recombination occurs during evolution of spore-forming Bacilli. ISME J. 2021;15(5):1344–58. doi: 10.1038/s41396-020-00854-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Baur M, Schulz NKE, Greune L, Länger ZM, Eirich J, Finkemeier I, et al. Immune priming in the insect gut: a dynamic response revealed by ultrastructural and transcriptomic changes [Internet]. bioRxiv; 2024. [cited 2024 Nov 26]. p. 2024.11.21.624623. Available from: https://www.biorxiv.org/content/10.1101/2024.11.21.624623v1 [Google Scholar]
  • 61.Bailey ZM, Igler C, Wendling CC. Prophage maintenance is determined by environment-dependent selective sweeps rather than mutational availability. Curr Biol. 2024;34(8):1739–49.e7. doi: 10.1016/j.cub.2024.03.025 [DOI] [PubMed] [Google Scholar]
  • 62.Desjardins E, Kurtz J, Kranke N, Lindeza A, Richter SH. Beyond Standardization: Improving External Validity and Reproducibility in Experimental Evolution. BioScience. 2021;71(5):543–52. doi: 10.1093/biosci/biab008 [DOI] [Google Scholar]
  • 63.Cobey S. Pathogen evolution and the immunological niche. Ann N Y Acad Sci. 2014;1320(1):1–15. doi: 10.1111/nyas.12493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Kussell E, Leibler S. Phenotypic diversity, population growth, and information in fluctuating environments. Science. 2005;309(5743):2075–8. doi: 10.1126/science.1114383. [DOI] [PubMed] [Google Scholar]
  • 65.Abdul-Rahman F, Tranchina D, Gresham D. Fluctuating environments maintain genetic diversity through neutral fitness effects and balancing selection. Mol Biol Evol. 2021;38(10):4362–75. doi: 10.1093/molbev/msab173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Yamamichi M, Letten AD, Schreiber SJ. Eco-evolutionary maintenance of diversity in fluctuating environments. Ecol Lett. 2023;26(Suppl 1):S152–67. doi: 10.1111/ele.14286 [DOI] [PubMed] [Google Scholar]
  • 67.Fortier LC, Sekulovic O. Importance of prophages to evolution and virulence of bacterial pathogens. Virulence. 2013;4(5):354–65. doi: 10.4161/viru.24498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Li S, Xu X, Shakeel M, Xu J, Zheng Z, Zheng J, et al. Bacillus thuringiensis Suppresses the Humoral Immune System to Overcome Defense Mechanism of Plutella xylostella. Front Physiol. 2018;9:1478.doi: 10.3389/fphys.2018.01478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Behrens S, Peuß R, Milutinović B, Eggert H, Esser D, Rosenstiel P, et al. Infection routes matter in population-specific responses of the red flour beetle to the entomopathogen Bacillus thuringiensis. BMC Genomics. 2014;15(1):445. doi: 10.1186/1471-2164-15-445 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Barclay VC, Sim D, Chan BHK, Nell LA, Rabaa MA, Bell AS, et al. The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi. PLoS Biol. 2012;10(7):e1001368. doi: 10.1371/journal.pbio.1001368 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Argôlo-Filho RC, Loguercio LL. Bacillus thuringiensis Is an Environmental Pathogen and Host-Specificity Has Developed as an Adaptation to Human-Generated Ecological Niches. Insects. 2013;5(1):62–91. doi: 10.3390/insects5010062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Rafaluk-Mohr C. The relationship between parasite virulence and environmental persistence: a meta-analysis. Parasitology. 2019;146(7):897–902. doi: 10.1017/S0031182019000015 [DOI] [PubMed] [Google Scholar]
  • 73.Schröter L, Dersch P. Phenotypic diversification of microbial pathogens-cooperating and preparing for the future. J Mol Biol. 2019;431(23):4645–55. doi: 10.1016/j.jmb.2019.06.024. [DOI] [PubMed] [Google Scholar]
  • 74.Spratt MR, Lane K. Navigating environmental transitions: the role of phenotypic variation in bacterial responses. mBio. 2022;13(6):e02212-22. doi: 10.1128/mbio.02212-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Chewapreecha C, Mather AE, Harris SR, Hunt M, Holden MTG, Chaichana C, et al. Genetic variation associated with infection and the environment in the accidental pathogen Burkholderia pseudomallei. Commun Biol. 2019;2(1):1–11.doi: 10.1038/s42003-019-0678-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Grau T, Vilcinskas A, Joop G. Sustainable farming of the mealworm Tenebrio molitor for the production of food and feed. Z Naturforschung C J Biosci. 2017;72(9–10):337–49. doi: 10.1515/znc-2017-0033. [DOI] [PubMed] [Google Scholar]
  • 77.Wang W, Wang L, Song L. The Immune Priming in Aquaculture Invertebrates: Inspiration From Cellular Perspective and Future Investigation. Rev Aquac [Internet]. 2024;. 17(1): 110347. doi: https://doi.org/10.1111/raq.12977 [Google Scholar]
  • 78.Peuß R, Wensing KU, Woestmann L, Eggert H, Milutinović B, Sroka MGU, et al. Down syndrome cell adhesion molecule 1: testing for a role in insect immunity, behaviour and reproduction. R Soc Open Sci. 2016;3(4):160138. doi: 10.1098/rsos.160138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303. doi: 10.1101/gr.107524.110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Poplin R, Chang P-C, Alexander D, Schwartz S, Colthurst T, Ku A, et al. A universal SNP and small-indel variant caller using deep neural networks. Nat Biotechnol. 2018;36(10):983–7. doi: 10.1038/nbt.4235 [DOI] [PubMed] [Google Scholar]
  • 81.Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10(2):giab008. doi: 10.1093/gigascience/giab008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Smolka M, Paulin LF, Grochowski CM, Horner DW, Mahmoud M, Behera S, et al. Detection of mosaic and population-level structural variants with Sniffles2. Nat Biotechnol. 2024;42(10):1571–80. doi: 10.1038/s41587-023-02024-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24–6. doi: 10.1038/nbt.1754 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80–92. doi: 10.4161/fly.19695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Arndt D, Grant JR, Marcu A, Sajed T, Pon A, Liang Y, et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Research. 2016;44(Web Server issue):W16-21.doi: 10.1093/nar/gkw387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2024. Available from: https://www.R-project.org/ [Google Scholar]
  • 87.RStudio Team. RStudio: Integrated Development for R [Internet]. PBC, Boston, MA: RStudio; 2023. Available from: www.rstudio.com [Google Scholar]
  • 88.Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1): 1–48. doi: https://doi.org/10.18637/jss.v067.i01. [Google Scholar]
  • 89.Stan Development Team. RStan: the R interface to Stan [Internet]. R package version 2.21.8. 2023. Available from: https://mc-stan.org/ [Google Scholar]
  • 90.Lobry JR, Bel-Venner MC, Bogdziewicz M, Hacket-Pain A, Venner S. The CV is dead, long live the CV!. Methods Ecol Evol. 2023;14(11):2780–6. doi: https://doi.org/10.1111/2041-210X.14197. [Google Scholar]
  • 91.Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest Package: Tests in Linear Mixed Effects Models. J Stat Softw. 2017;82(13): 1–26. doi: 10.18637/jss.v082.i13. [DOI] [Google Scholar]
  • 92.Diedenhofen B, Musch J. cocor: a comprehensive solution for the statistical comparison of correlations. PLoS One. 2015;10(3):e0121945. doi: 10.1371/journal.pone.0121945 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Debra E Bessen, Robert L Unckless

4 Mar 2025

PPATHOGENS-D-24-02760

Experimental evolution of a pathogen confronted with innate immune memory increases variation in virulence

PLOS Pathogens

Dear Dr. Korša,

Thank you for submitting your manuscript to PLOS Pathogens. After careful consideration, we feel that it has merit but does not fully meet PLOS Pathogens's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days May 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plospathogens@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/ppathogens/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Robert L. Unckless, Ph.D.

Academic Editor

PLOS Pathogens

Debra Bessen

Section Editor

PLOS Pathogens

 Sumita Bhaduri-McIntosh

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0003-2946-9497

 Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Additional Editor Comments (if provided):

Three experts in the field have reviewed your manuscript entitled "Experimental evolution of a pathogen confronted with innate immune memory increases variation in virulence". All three were enthusiastic about the work but pointed out significant concerns. All three reviewers point to references in the literature that should be considered in a revision and to a more careful grounding of the current hypotheses in terms of the available literature. From an editorial perspective, my biggest concern was raised by Reviewer #2 who asked whether the increased variance observed was the result of comparing technical to biological replicates in the experimental vs. control populations. If so, can we really say anything about increasing variance in the primed populations? All three reviewers also asked for more clarity in discussing aspects of the results (implications for selection, justification for fitness proxies, discussion of other virulence factors). Finally Reviewer #2 suggests a few additional experiments (pathogen load, pupation rate). I wonder whether you have that pupation rate data and could include it as another measure of fitness.

Journal Requirements:

[Note: HTML markup is below. Please do not edit.]

Reviewers' Comments:

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: This study uses an experimental evolution approach to test whether innate immune priming selects for higher pathogen virulence, using red flour beetles and their Bacillus pathogen as a model system. Understanding effects of innate immunity on virulence evolution is a very important and relevant question in many systems, and the authors use an ideal model system to test this question. Overall the methods and analysis are well done, and the results are quite interesting in that virulence did not increase, but became more variable after experimental evolution in primed hosts. I think overall that this is an exciting and important contribution to the literature.

Reviewer #2: The authors examined how immune priming by pathogens influences the evolution of virulence. While virulence did not differ across primed and control host treatments, there was greater variation in terms of virulence across replicates in primed hosts. Although this particular result was interesting, I have several concerns:

Line 95: The claim that this is the first study to show the influence of immune priming on pathogen evolution is not accurate. Previous studies, which the authors cited, have examined the interaction between live pathogen exposure (Read 2015), antigen exposure (Barclay 2012), and microbiota exposure (Hoang 2024), on the immune system and how they shape pathogen evolution. As immune priming is a general phenomenon, saying that immune priming has not been examined before in the context of pathogen evolution is misleading.

Line 360: With regards to specificity: has it been shown that nothing else could have triggered the same response from the beetle host?

The significant finding of this study, where variation increased across replicate populations, is interpreted as “evolutionary relevant because selection needs variation to act upon” (line 388). This interpretation is incorrect has evolution acts on the variation within a population, not across independently evolving populations.

Line 164: The increase in variation from the ancestor is due to the ancestor having technical replicates instead of biological replicates? So an increase in variation would be expected.

Lines 366 – 367: the way this is worded suggests that immune priming has been shown to maintain microbial variation through balancing or pleiotropic effects, when neither citation has to do with immune priming.

The Discussion was a bit too long in general.

Reviewer #3: In this study, Korša et al asked whether immune priming in the insect host Tribolium castaneum result in the evolution of increased virulence in the entomopathogenic bacteria Bacillus thuringiensis tenebrionis (Btt). Using a one-sided experimental evolution set-up, they subject Btt to undergo selection pressure in either an immune primed host or non-primed host for 8 selection cycles. To test the effects of their selection treatments, they performed a common garden experiment where evolved-lines of Btt and the ancestral strain were phenotyped for host-mortality (virulence) and spore load (transmission) in either an immune primed host or non-primed host environment. The authors observed that both evolved Btt lines did not increase virulence or transmission, in-fact they were reduced, when infecting primed or non-primed hosts. Interestingly, they found that the selection pressure of immune priming resulted in increased variation in Btt virulence. Genomic sequencing of these evolved strains revealed, when compared to the ancestral strain, minimal chromosomal mutations and reduced covered of the plasmid 188 kb, known to carry genes encoding virulence factors like the Cry toxin. The authors find some evidence that the evolved Btt lines have increased lytic phage activity, which could potentially explain reduced sporulation in those lines. While some additional experiments can help complete the presented work, this is an interesting study that interrogates whether incomplete immunity like immune priming can act as a selection pressure for bacteria pathogens to evolve virulence mechanisms against. The study appears mostly sound; however, the authors should revise the language to improve readability.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: My major concerns are all regarding presentation / interpretation. The main result is higher variation in virulence in pathogen lines evolved in primed hosts. This is quite interesting and I think can be highlighted even more strongly. I also would suggest using something other than variance as your metric presented in the results-I would encourage the authors to look at this paper which has been very helpful to my own lab group in thinking about how best to quantify differences in variability between groups: https://besjournals.onlinelibrary.wiley.com/doi/full/10.1111/2041-210X.14197

In terms of interpreting the variance result, in the discussion there is very little time spent on the implications of this for selection. At the very end, you note that such variation may boost evolutionary potential (line 389), yet you also saw no signal of directional selection because of this variability, which you note may reflect different evolutionary routes taken by each line. I think these implications are worth more focus in the discussion- do you think that evolutionary potential truly is higher in the primed treatments, and you just needed more generations of selection to see any signals of evolution? Overall I would have liked to see more extended discussion of the implications of what, to me, was a really interesting and exciting result (higher variation in bacterial lines evolved in primed hosts). This seems really novel and exciting, and broadly parallels some results we are finding in bacterial gene expression in songbirds with and without prior pathogen exposure (still as yet unpublished).

In several places (including Line 387) you conclude that you show an effect of specific immune priming on the evolution of bacterial virulence. Can you really state that given your results that virulence did not change, other than decreasing in both selected lines relative to the ancestral state? I think rewording may be needed.

Finally, this is more minor, but I think more justification for your proxy for “fitness” is needed- you simply note that you combine mortality rates and spore load data (Lines 199-200) but even in the methods, there is no justification for why this is a reasonable proxy for bacterial fitness in this system.

Reviewer #2: (No Response)

Reviewer #3: 1. What prior literature are the authors using to base their hypothesis that immune priming would evolve for higher virulence in Btt? They cite Hoang, et al (2024) and Rafaluk et al (2017) as examples of evolved higher virulence, but they also cite evidence from Ford, et al (2016) that pathogens evolve lower virulence. Mikonranta et al (2015, BMC Ecology and Evolution, https://doi.org/10.1186/s12862-015-0447-5) show that one-side evolution of Serratia marcescens DB11 in D. melanogaster resulted in reduced virulence, which the authors did not cite. It would be helpful to clarify what aspects from the literature motivate the authors hypothesis that Btt evolves higher virulence in response to immune priming.

2. In the second paragraph of the discussion section, the authors discuss three possible explanations to justify the observed lower virulence of evolved Btt lines: 1) evolution of high virulence is costly in the absence of co-evolution, 2) virulence factors encoded on mobile elements like plasmids are costly, 3) virulence evolution could be reduced due to other microbes in the host environment. While the authors do a great job discussing point two, the description of points one and three are minimal and could be expanded on what aspects of their study correspond with these points they cite? Additionally, in point 2, the authors discuss Cry toxins do not play a critical role for Btt virulence in beetles, so why focus on measuring Cry3Aa expression over other virulence factors? Were there any mutations observed in virulence factors like chitinases or proteases, or does plasmid 188kb encode additional virulence genes? Using the existing sequencing results, I think the current study would benefit from the addition of reporting of how other virulence factors were impacted in the evolved lines.

3. The potential increase in lytic phage activity in both evolved lines in Btt is interesting and I think could be expanded on in this study. In the double layer agar experiments, the ancestral strain acts as a negative control since it does not have active phages, so repeating this experiment and the other phenotypes measured (mortality and sporulation) with a Btt strain known to have active phages can be a positive control. Thus, if a Btt line with active phages show similar phenotypes to the evolved strains, potentially, this increased lytic activity maybe a mechanism for reduced virulence. Also, is there a difference in the number of phages between immune primed and non-immune primed evolved strains? The double-layer agar assay is quantifiable, so it should be feasible to score the number of phages to test whether the priming evolved and non-primed evolved strains differ.

4. One of the major findings in this paper is that evolution to immune priming results in increased variation to virulence, however, the authors only show host mortality as the only phenotype to demonstrate this. Increased host mortality is associated with higher virulence phenotypes in pathogens. Since the authors found that Btt evolved in beetle larvae exhibit reduced virulence, I think the study could be complemented by including at least one or two other disease phenotypes associated with virulence. For example, measuring Btt pathogen load during the course of infection or measure pupation rate of larvae that survive acute infection.

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: Line 151 – Is variance really the best measure here? See major comments.

Line 159 – can you justify why you used a beta distribution here, versus something like a gamma distribution? I didn’t see justification in the methods either.

Line 173- I suggest deleting the word “where”

Lines 391-393- The sentence “Not only the medical relevance…” is not grammatically complete.

Line 507- there is an error here in the reference source that needs updating.

Reviewer #2: Methods and Figures

Line 152: why is Fig. 2A presented after 2B?

Line 198: the p-value isn’t significant here? The significance threshold was not discussed in the Methods.

Lines 233: Was sequencing done at the population level instead of at the clonal? E.g., the heat map of Fig. 5 suggests allele frequencies within populations. What does this mean in terms of connection to the phenotypic results?

Lines 235 – 236: 32 unique variants?

Line 239: “position 2,017,894” isn’t really general wording. It doesn’t make sense without reading the Methods first.

The data points for Figs. 6a and 7b are not present like they are in previous figures.

Figure 6b: what is the p-value for? what test?

Other comments:

Lines 54 – 55: It is unclear why high virulence would be favored in non-tolerant hosts.

Line 63: what is external host immunity?

Line 65: are they contradictory results? They are just examples of ways that virulence evolutionary trajectories can be altered.

Line 67: Incomplete immunity is not defined

Line 90: I’m guessing this is host and not bacteria, in which case hosts are not evolving so they can’t have generations?

Lines 141 – 144: how is this different than the next paragraph?

Lines 221 – 222: Has cry3a been previously shown to affect virulence of Bt toward the beetle host? Or is this a hypothesis that cry3a is involved and has not been shown before?

Lines 316 – 317: Just a suggestion but it might be better to introduce the coverage data first showing lower cry3aa gene coverage, then go in and test for expression of this gene, and correlation between expression and coverage.

Lines 323 – 325: then why did the authors test this gene?

Lines 327 – 330: it is unclear what the logic is here

Line 331: do beetles have defensive microbes?

Line 372: what specifically about development?

Lines 392 – 393: how is immune priming being used in these fields?

Lines 507 – 508: error

Reviewer #3: Here, I list comments specific to each section of the manuscript.

Introduction:

• More detail on what the authors define as varying levels of virulence would provide welcome context here. For example, line 42 discusses intermediate levels of virulence of the Myxoma virus without describing exactly what intermediate virulence looks like in contrast to high. This could also be revisited in the discussion since the authors did not find evidence for immune primed evolved lines to increase virulence, potentially Btt evolved intermediate virulence mechanisms.

• More information on the activated immune response of primed Tenebrio castaneum vs an active immune response in infected, non-primed larvae would be additional context. For example, description of what are the primary effectors (e.g. antimicrobial peptides, ROS, immune cells) of T. castaneum that are upregulated after infection and priming and which aspect of the response primarily control Btt infection. Additionally, more information on the Btt infection cycle in larvae in the wild would-be helpful context such as including how larvae would encounter spores in nature and how spores reproduce and disperse from larvae cadavers.

• The authors briefly discuss how external host immunity (line 63) and defensive microbes (line 64) are examples of factors that can impact pathogen virulence without much detail on how they define these terms. For clarity, it would be helpful to provide additional context on the type of pathogen and the infecting host from these cited studies is helpful to know because unique properties of different pathogen species and their distinct host environment could influence what virulence strategies they evolve.

• Do the authors consider transmission as a form of virulence? I believe they are connected, but the authors should clarify what makes virulence and transmission distinct.

Results:

“Does host immune priming affect pathogen virulence evolution?” Section

Figure 1:

• What is the motivation or prior work used to justify performing 8 selection cycles, and how many generations of Btt (doubling time) occur during infection? The papers they cite like Hoang, et al (2024) performed 14 selection passages on P. aeruginosa and Ford, et al (2016) passaged Enterococcus faecalis and Staphylococcus aureus for 10 passages.

• For clarity, I think it is helpful to have a prescribed naming convention for the immune primed evolved Btt and the non-primed (author refers to control) evolved Btt to be distinct from the immune primed host environment and the control host environment.

Figure 2:

• Line 142-143: Here the authors are trying to directly compare average mortality between control hosts and primed hosts infected with ancestral, immune primed, and non-immune primed Btt. I think the data across these two figures should be compiled in the same graph if they are going to make direct make the comparisons between the two host environments.

• Line 145: What makes this analysis different than the one performed above? I'd explicitly state what type of model you created in the body of the results and what are the major factors being tested.

• Line 156: The authors state “the primed host, we observed higher variance in virulence across primed-evolved replicates (σ2 = 0.862) than in control evolved replicates (σ2 = 0.147).” What makes these results distinct from what is reported on lines 151-152? From my understanding both sentences are reporting on the same finding that Btt replicates evolved in primed hosts show higher variance in virulence than Btt controls when in a primed host. Since there are statistical comparisons being made in the text that are not present in the main figure texts, the authors should have a table reporting their statistical output.

• Figure 2 presentation:

o Include X axis title for 2A & 2B

o Y axis should include proportion

o The authors should present error bars for their boxplots throughout the text.

Figure S1:

• Line 164-What is the authors motivation for including this figure in the supplement? This seems like a significant finding from their evolution experiment (referenced even in the abstract).

“Do the evolved pathogens differ in spore production, sensitivity to priming and fitness?” Section

• Line 167: I believe the headers for these sections could be better served to state the primary finding from the results section. The questions posed in the headers could be better served to open the motivation for the experiments in each section.

Figure 3:

• Line 174: Swap figure order with Figure 3C since Figure 3D is mentioned first.

• Figure 3 presentation:

o The x and y axis should be a larger font.

o What is the unit of the Y axis? Is it on a log scale?

Figure 4:

• Line 194: In the legend the authors state what virulence is in this case, but it should be reflected in the text as well or more explicitly say host mortality.

• Line 205: The authors state “found a negative trend for the primed-evolved pathogens” when correlating priming sensitivity with pathogen fitness. What does this suggest?

“Do the evolved pathogens differ in 220 Cry gene expression?” Section

• Lines 224-225: When the authors discuss the statistics for the qPCR analysis, there needs to be a transition sentence between the discussion of the analysis that pools all the evolved lines together (lines 223-224) into the statistic performed for each experimental line relative to the ancestral strain.

“Do the evolved pathogens differ in their genomes and mobilome?” Section

• Figure 5 presentation: Need to indicate in figure legend what the darker and lighter colors mean for the heat map.

• Line 238: The authors mention virulent and non-virulent lines when referencing their genomics sequencing. What do the authors mean by this? In the figure 5 legend, they reference Fig. 2 for the order of virulence by evolved lines seen in the plot. The text of the results section does not formally report which of the evolved strains are the most and least virulent, which should be included.

• Line 271: The relative expression of the cry3Aa gene I assume is the qPCR expression measured in the previous section? This should be clarified in the body of the text when presenting Fig. 6B.

Figure S7:

• This supplementary figure needs clear labeling for what each of the plates represent. If possible, zoom in to a portion of the plate so the phage patches are distinct.

Discussion:

• Line 348: I do feel like these are reaches in the discussion and takes away focus from the paper. Could be worth future investigation to explore

• Line 357: Is it a fair comparison to make between pseudomonas and bacillus? Gram-negative vs Gram-positive bacteria could very likely evolve different trajectories since they vary greatly

• Line 361: What are the specific pathogen cues triggering immune priming in their study?

• Line 377: While measuring the host’s immune response to evolved pathogens could be a follow-up study, I think it could be a worthy addition to the paper to compare a more virulent evolved line vs a less virulent evolved line to see how they may impact the hosts immune response. Else, I think this point could be further clarified in the discussion of known examples of pathogens that reduce the immune response in beetle larvae.

Methods:

• Line 489: How long were these cadavers sitting before being homogenized? For the selection experiment above it says the authors waited 7 days. Is that what is happening here?

• Line 560: What do the authors define as plate in this model?

• Line 581: The authors determined Btt fitness in the host by “combining the spore load and proportion of mortality”. How was this performed? Were they summed, made relative to each other? They also mention this in the results section (line 199-200) but do not clarify how they combined these values together.

Grammar:

Below are a few examples in the text that could be rephrased for clarity. Working with a copyeditor could help improve the flow of the text.

• Line 141-142: The authors write ‘Regarding the host environment encountered during the readout, i.e. after evolution had happened’. They use ‘i.e.’ frequently throughout the text, so it could help readability to make sentences like this more succinct.

• Line 398: Sentences starts with “As pathogen”, this can be rephrased.

• Line 507: Possible error with citation manager?

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Attachment

Submitted filename: PPATHOGENS-D-24-02760_reviewer_AMDreport.docx

ppat.1012839.s011.docx (24.4KB, docx)

Decision Letter 1

Debra E Bessen, Robert L Unckless

7 May 2025

Dear Dr. Korša,

We are pleased to inform you that your manuscript 'Experimental evolution of a pathogen confronted with innate immune memory increases variation in virulence' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Robert L. Unckless, Ph.D.

Academic Editor

PLOS Pathogens

Debra Bessen

Section Editor

PLOS Pathogens

Sumita Bhaduri-McIntosh

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0003-2946-9497

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Two expert scientists have reviewed your resubmission "Experimental evolution of a pathogen confronted with innate immune memory increases variation in virulence". Both were enthusiastic about the reviews and the likely impact of the manuscript. Reviewer 1 had a few minor points that should be considered. I look forward to seeing this published.

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: Overall the authors have addressed my major concerns thoroughly.

Reviewer #3: The authors satisfactorily integrated my feedback and that of the other reviewers. I think these greatly improved the paper, so I recommend its acceptance for publication.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: None

Reviewer #3: (No Response)

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: In the second paragraph of the Introduction (Line 73 of the version withOUT track changes), I think it may be a bit hard for readers to follow the logic here without some clarification. Perhaps change the word "actual" to "realized" or something like that? It is always tricky to distinguish between the pathogen's inherent virulence phenotype and the realized virulence in the host, given the hosts background. I also think it would help to add "in hosts with tolerance" to the end of that sentence so that it reads:

"The evolution of tolerance, for instance, can strongly influence the evolution of virulence... without increasing the realized level of virulence IN HOSTS WITH TOLERANCE."

My other editorial comment just relates to the length of that second paragraph. It is quite long and I think could be broken up in 1 or 2 places. Two obvious candidates are:

Line 80 (in version without tracked changes)- new paragraph at "Virulence evolution is a complex trait..."

AND/OR

Line 93- new paragraph at "Invertebrate immune priming has been suggested..."

Reviewer #3: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #3: No

Acceptance letter

Debra E Bessen, Robert L Unckless

Dear Dr. Korša,

We are delighted to inform you that your manuscript, "Experimental evolution of a pathogen confronted with innate immune memory increases variation in virulence," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Sumita Bhaduri-McIntosh

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0003-2946-9497

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. qPCR primers and their amplification efficiencies.

    (DOCX)

    ppat.1012839.s001.docx (12.7KB, docx)
    S2 Table. Relative expression of Cry3a gene in cultures from different Btt strains.

    Btt- and Bt407- do not carry the Cry3a gene. Priming and control lines were evolved from ancestral strain. Mean ΔCt values by subtracting the target gene Ct value from the geometric mean of the Ct values of the housekeeping genes.

    (DOCX)

    ppat.1012839.s002.docx (12.8KB, docx)
    S3 Table. Differences of Cry3a gene expression of individual evolved lines compared to the ancestral strain.

    Shown are the results of linear mixed effects model with block as experimental factor. Significant differences are shown in bold type face.

    (DOCX)

    ppat.1012839.s003.docx (14.2KB, docx)
    S1 Fig. Correlation between spore load and virulence in ancestral line (A), control line(C) and primed line (P) in primed hosts.

    (DOCX)

    ppat.1012839.s004.docx (19.7KB, docx)
    S2 Fig. Correlation between spore load and virulence in ancestral line (A), control line(C) and primed line (P) in primed beetle larvae in control host.

    (DOCX)

    ppat.1012839.s005.docx (19.3KB, docx)
    S3 Fig. Relative expression of Cry3a gene for evolved lines.

    ΔCt values were calculated by subtracting the Ct value of the target gene, Cry3A from the geometric mean of the Ct values of two housekeeping genes (Yqey and rps21).

    (DOCX)

    ppat.1012839.s006.docx (91.5KB, docx)
    S4 Fig. Heatmap for the Log2 transformed values of plasmid coverage divided by chromosome coverage for each replicate line.

    A = ancestral, C = control evolved, P = primed evolved.

    (DOCX)

    ppat.1012839.s007.docx (59.2KB, docx)
    S5 Fig. Exemplary log2 transformed mean-normalized coverage plots of reads across the chromosome for control (C1 – 4) and priming (P1 – 4) evolved lines.

    (DOCX)

    ppat.1012839.s008.docx (161.5KB, docx)
    S6 Fig. Double layer agar assays of an ancestral line A and evolved lines C1 (control evolved) and P7 (priming evolved).

    (DOCX)

    ppat.1012839.s009.docx (724.1KB, docx)
    S7 Fig. Pearson correlation matrix for the primed evolved pathogen (A, C) and the control evolved pathogen (B, D).

    Correlated traits include all phenotypic traits with active mobile elements (A, B) or Fitness and Priming sensitivity values with active mobile elements (C, D).

    (DOCX)

    ppat.1012839.s010.docx (77KB, docx)
    Attachment

    Submitted filename: PPATHOGENS-D-24-02760_reviewer_AMDreport.docx

    ppat.1012839.s011.docx (24.4KB, docx)
    Attachment

    Submitted filename: Answer_revision_21_3.doc

    ppat.1012839.s013.doc (328.5KB, doc)

    Data Availability Statement

    The genomic sequences can be found on NCBI under Bioproject number: PRJNA1174726. All the data sets, code, and RMarkdown file with figures and analysis results can be found in Zenodo depository: https://doi.org/10.5281/zenodo.15050213


    Articles from PLOS Pathogens are provided here courtesy of PLOS

    RESOURCES